MY105512A - Azabenzimidazoles in the treatment of asthma, arthritis and related diseases. - Google Patents
Azabenzimidazoles in the treatment of asthma, arthritis and related diseases.Info
- Publication number
- MY105512A MY105512A MYPI91000776A MYPI19910776A MY105512A MY 105512 A MY105512 A MY 105512A MY PI91000776 A MYPI91000776 A MY PI91000776A MY PI19910776 A MYPI19910776 A MY PI19910776A MY 105512 A MY105512 A MY 105512A
- Authority
- MY
- Malaysia
- Prior art keywords
- arthritis
- asthma
- azabenzimidazoles
- treatment
- related diseases
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 abstract 2
- 108010003541 Platelet Activating Factor Proteins 0.000 abstract 2
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical class C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 abstract 1
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 230000009429 distress Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000002107 myocardial effect Effects 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52119990A | 1990-05-09 | 1990-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY105512A true MY105512A (en) | 1994-10-31 |
Family
ID=24075786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI91000776A MY105512A (en) | 1990-05-09 | 1991-05-08 | Azabenzimidazoles in the treatment of asthma, arthritis and related diseases. |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP0533695B1 (en, 2012) |
| JP (1) | JPH0678340B2 (en, 2012) |
| CN (1) | CN1057839A (en, 2012) |
| AP (1) | AP224A (en, 2012) |
| AT (1) | ATE112567T1 (en, 2012) |
| AU (1) | AU642265B2 (en, 2012) |
| BG (1) | BG97059A (en, 2012) |
| BR (1) | BR9106433A (en, 2012) |
| CA (1) | CA2080476A1 (en, 2012) |
| DE (1) | DE69104481T2 (en, 2012) |
| DK (1) | DK0533695T3 (en, 2012) |
| ES (1) | ES2061247T3 (en, 2012) |
| FI (1) | FI925053A0 (en, 2012) |
| GT (1) | GT199100031A (en, 2012) |
| HU (1) | HUT62894A (en, 2012) |
| IE (1) | IE911553A1 (en, 2012) |
| IL (1) | IL98075A0 (en, 2012) |
| MA (1) | MA22151A1 (en, 2012) |
| MY (1) | MY105512A (en, 2012) |
| NO (1) | NO924290D0 (en, 2012) |
| NZ (1) | NZ238089A (en, 2012) |
| PE (1) | PE26691A1 (en, 2012) |
| PT (1) | PT97616A (en, 2012) |
| RO (1) | RO109450B1 (en, 2012) |
| TW (1) | TW205549B (en, 2012) |
| WO (1) | WO1991017163A1 (en, 2012) |
| YU (1) | YU81191A (en, 2012) |
| ZA (1) | ZA913497B (en, 2012) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9102997D0 (en) * | 1991-02-13 | 1991-03-27 | Pfizer Ltd | Therapeutic agents |
| AU5016793A (en) * | 1992-08-20 | 1994-03-15 | Cytomed, Inc | Dual functional anti-inflammatory and immunosuppressive agents |
| US6372770B1 (en) | 1994-10-12 | 2002-04-16 | Euro-Celtique, S.A. | Benzoxazoles |
| CN1308622A (zh) * | 1998-05-12 | 2001-08-15 | 美国家用产品公司 | 用于治疗胰岛素抗性和高血糖的联苯基氧代－乙酸 |
| US6232322B1 (en) | 1998-05-12 | 2001-05-15 | American Home Products Corporation | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6310081B1 (en) | 1999-05-10 | 2001-10-30 | American Home Products Corporation | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| JP2016537398A (ja) * | 2013-09-13 | 2016-12-01 | コーテンドー エービー（ピーユービーエル）Ｃｏｒｔｅｎｄｏ Ａｂ（Ｐｕｂｌ） | 新規なチトクロムｐ４５０阻害剤及びこれらの使用方法 |
| CN105348182B (zh) * | 2014-08-24 | 2018-04-13 | 复旦大学 | 2‑烷氧基苯甲酰芳胺类化合物及其药物用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8401486A1 (es) * | 1981-11-10 | 1983-12-01 | Wellcome Found | Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina. |
| GB8804439D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Dihydropyridines |
| GB8822170D0 (en) * | 1988-09-21 | 1988-10-26 | Pfizer Ltd | Therapeutic agents |
-
1991
- 1991-05-01 FI FI925053A patent/FI925053A0/fi not_active Application Discontinuation
- 1991-05-01 BR BR919106433A patent/BR9106433A/pt not_active Application Discontinuation
- 1991-05-01 RO RO92-01395A patent/RO109450B1/ro unknown
- 1991-05-01 EP EP91909431A patent/EP0533695B1/en not_active Expired - Lifetime
- 1991-05-01 DE DE69104481T patent/DE69104481T2/de not_active Expired - Fee Related
- 1991-05-01 AT AT91909431T patent/ATE112567T1/de not_active IP Right Cessation
- 1991-05-01 DK DK91909431.8T patent/DK0533695T3/da active
- 1991-05-01 AU AU78671/91A patent/AU642265B2/en not_active Ceased
- 1991-05-01 JP JP3509156A patent/JPH0678340B2/ja not_active Expired - Fee Related
- 1991-05-01 CA CA002080476A patent/CA2080476A1/en not_active Abandoned
- 1991-05-01 ES ES91909431T patent/ES2061247T3/es not_active Expired - Lifetime
- 1991-05-01 HU HU923496A patent/HUT62894A/hu unknown
- 1991-05-01 WO PCT/US1991/002997 patent/WO1991017163A1/en active IP Right Grant
- 1991-05-07 IL IL98075A patent/IL98075A0/xx unknown
- 1991-05-08 TW TW080103606A patent/TW205549B/zh active
- 1991-05-08 MA MA22421A patent/MA22151A1/fr unknown
- 1991-05-08 AP APAP/P/1991/000259A patent/AP224A/en active
- 1991-05-08 NZ NZ238089A patent/NZ238089A/en unknown
- 1991-05-08 ZA ZA913497A patent/ZA913497B/xx unknown
- 1991-05-08 IE IE155391A patent/IE911553A1/en unknown
- 1991-05-08 MY MYPI91000776A patent/MY105512A/en unknown
- 1991-05-08 PE PE1991185432A patent/PE26691A1/es unknown
- 1991-05-08 CN CN91103959A patent/CN1057839A/zh active Pending
- 1991-05-09 PT PT97616A patent/PT97616A/pt not_active Application Discontinuation
- 1991-05-09 GT GT199100031A patent/GT199100031A/es unknown
- 1991-05-09 YU YU81191A patent/YU81191A/sh unknown
-
1992
- 1992-11-06 NO NO924290A patent/NO924290D0/no unknown
- 1992-11-06 BG BG097059A patent/BG97059A/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT46638A (en) | Process for producing 1,1,1-trifluoro-2,2-dichloroethane in the presence of hydrogen fluoride catalyst | |
| HU908147D0 (en) | Process for the production of n-(pyrrolo/2,3-d/pyrimidine-3-yl-acyl)-glutamine-acid derivatives | |
| IT8149993A0 (it) | Procedimento per la produzione del fattore di stimolo della differenziazione cellulare nell'uomo | |
| AP8800106A0 (en) | Substituted tetrarins chromans & related compounds in the treatment of asthma,arthritis etc. | |
| MY105512A (en) | Azabenzimidazoles in the treatment of asthma, arthritis and related diseases. | |
| EP0232061A3 (en) | High-strength steel for valve springs process for producing the steel, and valve springs made of the same | |
| FI961564A7 (fi) | Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit | |
| IT1231549B (it) | Procedimento per la produzione di semilavorati di cuoio | |
| EP0589641A3 (en) | Method of producing wear resistant articles | |
| NO180587C (no) | Fremgangsmåte for fremstilling av 5-substituerte pyrrolo(2,3-d)pyrimidiner | |
| FI943765A7 (fi) | 4-aminopyridiinin käyttö neurologisen tilan hoidossa | |
| AU9071291A (en) | Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy | |
| PT78603B (en) | Process for preparing 1,8-dihidroxy-10-acyl-9-anthrones especially for use in the treatment of psoriasis | |
| EP0436831A3 (en) | Imidazo(1,2-a)pyridinylalkyl compounds for treatment of neurotoxic injury | |
| IT8149754A0 (it) | Procedimento per la produzione di imidazo (4,5-b)-piridine e imidazo (4,5-b)-pirimidine | |
| HU913296D0 (en) | Process for the production of 5,11-dihydro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepines | |
| ZA928096B (en) | Heterocyclic compounds and their preparation and use | |
| ITMI912811A1 (it) | Mattonelle per l'impiego in processi di fusione del silicio e metodo per la loro produzione | |
| HU913860D0 (en) | Multi-purpose disinfectant, process for its production and use | |
| TW239116B (en, 2012) | ||
| IT8321143A0 (it) | Enantiomeri di esaidro-2,3,3a,4,5,61h-indol [3,2,1-de] [naftiridina1,5], processo di loro separazione e loro impiego in terapeutica | |
| DE3875807D1 (de) | 3-acylaminomethyl-5,6,7,8-tetrahydroimidazo(1,2-a)pyridinderivate, ihre herstellung und therapeutische verwendung. | |
| IT8922522A0 (it) | Processo per l'estrazione da fluidi di microinquinanti organici, utilizzando macrocicli sintetici riattivabili | |
| ITMI921595A0 (it) | Metodo ed apparecchiatura per sottoporre ad operazioni di rifinitura quale smerigliatura o similare, corpi di rivoluzione quali pentole o similari | |
| IT8747734A0 (it) | Procedimento ed apparecchio per laproduzione di 5-metil-7-dietilammino-s-triazolo (1,5-a)pirimidina |